Pharma Marketing Blog: The Year 2011 in Images

55,726 views

Published on

These are my favorite images that appeared in Pharma Marketing Blog posts made in 2011.

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
55,726
On SlideShare
0
From Embeds
0
Number of Embeds
53,964
Actions
Shares
0
Downloads
21
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Pharma Marketing Blog: The Year 2011 in Images

  1. 1. The Year 2011 in Images These are my favorite images that appeared in Pharma Marketing Blog posts made in 2011. Pharma Marketing Blog 2011: The Year in Images 2011. Pharma Marketing Network. All rights reserved.
  2. 2. FDA’s Guidance Sausage Making Process FDA carved out “high priority guidances” for which it would publish development timelines. No such timeline, however, has been made public for social media guidelines that were first promised to be published by the end of 2010! FDA Says There are "No simple solutions" to Speed Up Its Regulatory Guidance Process Posted on January 10, 2011. Pharma Marketing Blog 2011: The Year in Images 2011. Pharma Marketing Network. All rights reserved.
  3. 3. Is It Time for Abrams to Leave FDA? Office of Prescription Drug Promotion Director Tom Abrams did not deliver on his promises for social media guidelines. Perhaps it‟s time for him to leave the FDA and join PhRMA or a Washington think tank/PR agency. Is It Time for Abrams to Leave? Posted on February 11, 2011. Pharma Marketing Blog 2011: The Year in Images 2011. Pharma Marketing Network. All rights reserved.
  4. 4. AZ Hosts First-Ever Pharma Twitter Chat Despite dire predictions of “PR failure,” the #rxsave Twitter chat hosted by @AstraZenecaUS was a great success and proof that a pharmaceutical company can indeed host meaningful Twitter chats.OMG! AstraZeneca Hosts Twitter Chat & World Does NOT End! Posted on February 17, 2011. Pharma Marketing Blog 2011: The Year in Images 2011. Pharma Marketing Network. All rights reserved.
  5. 5. Phil Mickelson Shills for Enbrel After Phil became an official Enbrel spokes- person, he had to tone down his endorsement from “I feel stronger and more flexible than Ive ever been” to “I like where I am physically and am optimistic about 2011.” Phil Mickelson "Opens Up" to Arthritis Today Magazine Posted on February 21, 2011. Pharma Marketing Blog 2011: The Year in Images 2011. Pharma Marketing Network. All rights reserved.
  6. 6. Real Patients Star in Pharma Youtube Videos Pharma marketers save a bundle repurposing videos for Youtube. They save even more money by hiring real patients to play themselves in these videos! Patients are natural method actors, having actually experienced what they portray. But they are prone to over emote! Method Acting for Real Patients Who Play Themselves on Pharma YouTube Channels Posted on February 25, 2011. Pharma Marketing Blog 2011: The Year in Images 2011. Pharma Marketing Network. All rights reserved.
  7. 7. What’s Behind Pharma Mobile Apps? Many pharmaceutical marketers are developing mobile Apps. Some are designed for physician use during diagnoses of patients. Are these “medical devices” subject to regulation? Do dis- claimers adequately warn users of limitations? Who checks the software behind the app? Is it accurate? What personal user information is being collected? FDA Promises Still More Guidance! This Time Its Mobile. Janssens Psoriasis iPhone App May Need It. Posted on March 16, 2011. Pharma Marketing Blog 2011: The Year in Images 2011. Pharma Marketing Network. All rights reserved.
  8. 8. Drug Development Cost Conflict How is it that the Tufts estimate is at least 14 TIMES the London School of Economics and Political Science (LSEPS) estimate? “Make no mistake,” said Tufts. “Tufts CSDD will vigorously defend the scholarship, integrity, an d validity of all its publish-ed research studies.” A New Estimate of Drug Development Cost Posted on April 23, 2011. Pharma Marketing Blog 2011: The Year in Images 2011. Pharma Marketing Network. All rights reserved.
  9. 9. Enough Bullsh*t Already! The FDA has not issued expected social media guidelines for pharma. But it has commissioned “further studies! Update: On 27 December 2011, FDA issued guidance on responding to off-label FDAs Proposed Web Study Will Further requests, which included Delay Social Media Guidelines social media guidelines. Posted on April 28, 2011. FDA Guidance on Responding to UnsolicitedRequests for Off-Label Information Via Social Media Posted on December 28, 2011. Pharma Marketing Blog 2011: The Year in Images 2011. Pharma Marketing Network. All rights reserved.
  10. 10. Pharma’s Worst Enemy Is Itself Majority of Bad Ad Complaints Submitted by Pharma "Representatives" Deemed Worthy of "Comprehensive Review" by FDA Posted on May 13, 2011.According to a Bad Ad Program 2010-2011 Year EndReport, 125 complaints were deemed worthy of “comprehensivereview.” The majority of these (58% or more) came from pharmasources. Pharma Marketing Blog 2011: The Year in Images 2011. Pharma Marketing Network. All rights reserved.
  11. 11. Are PR Agencies Social Media Idiots? Who should be in charge of pharma‟s social media programs – Public Relations agencies or specialized Interactive agencies? The debate began here. The winner will get mere crumbs from pharma‟s total promotional pie.PR vs Interactive: Agencies Vie for Pharma Social Media Campaign Crumbs Posted on May 13, 2011. Pharma Marketing Blog 2011: The Year in Images 2011. Pharma Marketing Network. All rights reserved.
  12. 12. Where in the World is Pfizer’s Social Media Playbook? We‟ve looked high and we‟ve looked low, but we haven‟t found Pfizer‟s “ground-breaking internal Social Media Playbook.” Pfizer, Show Us Your Social Media "Playbook" Posted on July 14, 2011. Pharma Marketing Blog 2011: The Year in Images 2011. Pharma Marketing Network. All rights reserved.
  13. 13. Pharma Followers Trump ContentWhat‟s more important? The number of followers pharma has onTwitter or the content? Pfizer vs. Sanofi is a great case study. Pharma Tweets: Followers Trump Content. Pfizer vs. Sanofi Case Study Posted on August 5, 2011. Pharma Marketing Blog 2011: The Year in Images 2011. Pharma Marketing Network. All rights reserved.
  14. 14. Suspend Your Disbelief in Pharma Pharma Planet of the Apes! Posted on August 8, 2011.A PhRMA blogger urged us NOT to “suspend our disbelief” whenviewing the new Planet of the Apes movie. This image depictswhat might happen if we don‟t follow this advice. Pharma Marketing Blog 2011: The Year in Images 2011. Pharma Marketing Network. All rights reserved.
  15. 15. Flash Mob Attacks Pharma FB Page Using the same social media tools mobs used to disrupt life in London, online disgruntled patient mobs could be organized to attack pharma Facebook pages. Can this – did this! – happen?Social Media "Flash Mobs": Pharmas Worst Facebook Nightmare! Posted on August 19, 2011. Pharma Marketing Blog 2011: The Year in Images 2011. Pharma Marketing Network. All rights reserved.
  16. 16. How Many Patients Are Needed to Yield a Billion Dollars in Sales? That is a trick question. It depends on the type of drug. For a drug such as Pfizer‟s Xalkori, it only takes 9,000 patients! New Big Pharma Economies of Scale: Less Patients Needed to Reach Blockbuster Sales Posted on August 30, 2011. Pharma Marketing Blog 2011: The Year in Images 2011. Pharma Marketing Network. All rights reserved.
  17. 17. Say “Rat Poison” First Boehringer Ingelheim (BI) launched an incredibly odd Youtube video about training parrots to spread the word about BI (“we take this literally,” said a BI tweet). Then, news stories broke about how BI train-ed journalists to “dis” the competition! BI Masters the Art of WOM through Its "Parrots," er, Spokespersons Posted on September 21, 2011.Pharma Marketing Blog 2011: The Year in Images 2011. Pharma Marketing Network. All rights reserved.
  18. 18. Pharma’s 2010 DTC Ad Spend As I have often noted, digital display ad spending is only a minor fraction of pharmas overall DTC advertising budget. In 2010, digital represented only 4.7% of total DTC spending. Double Dip in DTC Spending Plus 33% Drop in Internet Display Ad Spending! Posted on October 22, 2011. Pharma Marketing Blog 2011: The Year in Images 2011. Pharma Marketing Network. All rights reserved.
  19. 19. Channeling Steve Jobs There‟s a lot of buzz about pharma‟s current lack of innovative new products in the “pipeline” and what needs to be done about it. At the same time, many execs are wondering how to be more like Steve Jobs. How about taking this challenge channeled via Steve Jobs? Channeling Steve Jobs to Solve Pharmas Innovators Dilemma Posted on October 26, 2011.Pharma Marketing Blog 2011: The Year in Images 2011. Pharma Marketing Network. All rights reserved.
  20. 20. A Pharma Game I’d Like to See Boehringer Ingelheim‟s long-awaited “Syrum” game may be nothing more than vaporware. When it is available, it probably will not be as popular as “Angry PhRMA,” which mimics real world “knock „em out, drag „em out” pharma politics! Pharma & Fun, Not Oxymoronic? Here Comes Gamification! Posted on October 27, 2011. Pharma Marketing Blog 2011: The Year in Images 2011. Pharma Marketing Network. All rights reserved.
  21. 21. Smartass Pfizer Caught "ChapStick posts weird image on Facebook of a woman, ass in the air, looking for her ChapStick behind a couch,” reported AdWeek. Pfizer‟s first reaction: delete all com-plaints posted on its FB page! “Social Media Pfizers Facebook Fiasco: Chapstick Death Spiral” ensues.Slapstick Ad Uses Womans Ass as a Prop Posted on October 27, 2011. Pharma Marketing Blog 2011: The Year in Images 2011. Pharma Marketing Network. All rights reserved.
  22. 22. There are No Dead Patient Testimonials A new study claims that Chantix is “eight times more likely to be linked with a reported case of suicidal behavior or depression than other nicotine replacement products.” You won‟t learn that from Chantix patient testimonials on TV – dead patients are silent. Chantix May Be More Dangerous Than Smoking! Posted on November 3, 2011. Pharma Marketing Blog 2011: The Year in Images 2011. Pharma Marketing Network. All rights reserved.
  23. 23. Let Off-Label Free Speech Free! Is pharma “uniquely position- ed” to provide doctors with “objective, balanced, and accurate information on important unapproved uses of approved products?” Pharma Turns Up the Heat on Off-Label "Free Speech" Chilled by FDA - Implications for Social Media Marketing Posted on November 8, 2011. Pharma Marketing Blog 2011: The Year in Images 2011. Pharma Marketing Network. All rights reserved.
  24. 24. Legal Challenges Thwart Social Media Guidelines Has issuance of social media & other guidelines for the pharmaceutical industry been delayed by worries about pharma‟s overt and implied legal challenges to FDA‟s authority to issue such guidance?FDA Social Media Guidelines May Be Moot Is the Pharma Industry Responsible for If This Court Decision Holds Up FDAs Delay in Issuing Social Media Posted on December 28, 2011. Guidelines? Posted on December 2, 2011. Pharma Marketing Blog 2011: The Year in Images 2011. Pharma Marketing Network. All rights reserved.
  25. 25. Science Takes a Back Seat to Politics “If I close my eyes...I might think I was in the Bush era,” said Michelle Goldberg, Senior writer for Newsweek. Science takes a back seat to politics as HHS Secretary Sebelius over-rules FDA Commissioner Hamburg on Plan B decision.December 7, 2011: A Date Which Will Live in Infamy for Womens Health! Posted on December 7, 2011. Pharma Marketing Blog 2011: The Year in Images 2011. Pharma Marketing Network. All rights reserved.
  26. 26. Have a Happy New Year! Pharma Marketing Blog 2011: The Year in Images 2011. Pharma Marketing Network. All rights reserved.

×